Sedia Biosciences Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Sedia Biosciences General Information

Description

Developer of medical devices and diagnostics intended to estimate the incidence of human immunodeficiency virus in individuals, populations, countries, and regions. The company's devices provide surveillance, monitoring, and point-of-care diagnostic testing through in-vitro diagnostic test kits, epidemiological tests, and specimen collection devices, enabling patients to have access to medical care by developing cost-effective products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9590 SouthWest Gemini Drive
  • Beaverton, OR 97008
  • United States
+1 (503)
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Vertical(s)
Corporate Office
  • 9590 SouthWest Gemini Drive
  • Beaverton, OR 97008
  • United States
+1 (503)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sedia Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Grant 19-Dec-2018 Completed Generating Revenue
4. Grant 01-Jan-2016 Completed Generating Revenue
3. Grant 01-Jan-2014 Completed Startup
2. Seed Round 11-Jul-2013 $500K $500K Completed Startup
1. Grant 01-Jan-2012 $194K Completed Startup
To view Sedia Biosciences’s complete valuation and funding history, request access »

Sedia Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices and diagnostics intended to estimate the incidence of human immunodeficiency virus in indiv
Diagnostic Equipment
Beaverton, OR
23 As of 2026

Richmond, Canada
 

Medford, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sedia Biosciences Competitors (4)

One of Sedia Biosciences’s 4 competitors is BioLytical Laboratories, a Corporation company based in Richmond, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioLytical Laboratories Corporation Richmond, Canada
Chembio Diagnostic Systems Corporate Backed or Acquired Medford, NY
Illumina Formerly VC-backed San Diego, CA
Orasure Technologies Corporate Backed or Acquired Bethlehem, PA
To view Sedia Biosciences’s complete competitors history, request access »

Sedia Biosciences Patents

Sedia Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3746787-A1 A rapid quantitative assay to assess duration of infection Inactive 01-Feb-2018
EP-3746787-A4 A rapid quantitative assay to assess duration of infection Inactive 01-Feb-2018
WO-2019152498-A1 A rapid quantitative assay to assess duration of infection Inactive 01-Feb-2018
US-20200355681-A1 Rapid quantitative assay to assess duration of infection Inactive 01-Feb-2018
US-20230417745-A1 Rapid quantitative assay to assess duration of infection Pending 01-Feb-2018 G01N33/54388
To view Sedia Biosciences’s complete patent history, request access »

Sedia Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sedia Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Business Oregon Government
National Institute Of Allergy and Infectious Diseases Government
To view Sedia Biosciences’s complete investors history, request access »

Sedia Biosciences Acquisitions (1)

Sedia Biosciences’s most recent deal was a Merger/Acquisition with Floragenex. The deal was made on 19-Oct-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Floragenex 19-Oct-2016 Merger/Acquisition Biotechnology
To view Sedia Biosciences’s complete acquisitions history, request access »

Sedia Biosciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Floragenex Beaverton, OR 2007

Sedia Biosciences FAQs

  • When was Sedia Biosciences founded?

    Sedia Biosciences was founded in 2009.

  • Where is Sedia Biosciences headquartered?

    Sedia Biosciences is headquartered in Beaverton, OR.

  • What is the size of Sedia Biosciences?

    Sedia Biosciences has 23 total employees.

  • What industry is Sedia Biosciences in?

    Sedia Biosciences’s primary industry is Diagnostic Equipment.

  • Is Sedia Biosciences a private or public company?

    Sedia Biosciences is a Private company.

  • What is Sedia Biosciences’s current revenue?

    The current revenue for Sedia Biosciences is .

  • How much funding has Sedia Biosciences raised over time?

    Sedia Biosciences has raised $500K.

  • Who are Sedia Biosciences’s investors?

    Business Oregon and National Institute Of Allergy and Infectious Diseases have invested in Sedia Biosciences.

  • Who are Sedia Biosciences’s competitors?

    BioLytical Laboratories, Chembio Diagnostic Systems, Illumina, and Orasure Technologies are competitors of Sedia Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process